Following promising clinical results, retatrutide, a novel peptide treatment for treating type 2 metabolic disorder, has received regulatory approval from UK’s Healthcare and Regulatory Agency ( MHRA https://shopretatrutidepeptide.com/category/retatrutide-peptide/